
DACT2 Epigenetic Stimulator Exerts Dual Efficacy for Colorectal Cancer Prevention and Treatment
Keywords: 5aza; thioguanine and 5-azacytidine; AOM; azoxymethane; CRC; clinical colorectal cancer; DACT2; dishevelled binding antagonist of beta catenin 2; DAI; disease activity index; DNMTs; DNA methyltransferases; DSS; dextran sodium sulfate; HDACs; histone deace